However, Lynch syndrome was characterized by increased CD8+ T cells but decreased PD-L1+ macrophages, suggesting that patients with Lynch syndrome EC was less responsive to single-agent anti-PD-L1 or anti-PD-1 therapies [20]. Here, CD8A is linked to Lynch syndrome.